Free Trial

Extendicare Q1 2023 Earnings Report

Extendicare logo
C$10.02 -0.10 (-0.99%)
(As of 05:28 PM ET)

Extendicare EPS Results

Actual EPS
C$0.14
Consensus EPS
C$0.06
Beat/Miss
Beat by +C$0.08
One Year Ago EPS
N/A

Extendicare Revenue Results

Actual Revenue
$324.71 million
Expected Revenue
$299.70 million
Beat/Miss
Beat by +$25.01 million
YoY Revenue Growth
N/A

Extendicare Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Uncover the Top Gold Stock of the Bull Market (Ad)

Gold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?

Click here to see how this opportunity could transform your portfolio.

Extendicare Earnings Headlines

URGENT: This Altcoin Opportunity Won’t Wait – Act Now
It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.
Where to Invest $5,000 in October
See More Extendicare Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Extendicare? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Extendicare and other key companies, straight to your email.

About Extendicare

Extendicare (TSE:EXE), through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.

View Extendicare Profile

More Earnings Resources from MarketBeat

Upcoming Earnings